228 related articles for article (PubMed ID: 3096130)
1. The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam.
Jones RN; Barry AL; Thornsberry C; Fuchs PC; Packer RR
Am J Clin Pathol; 1986 Nov; 86(5):608-18. PubMed ID: 3096130
[TBL] [Abstract][Full Text] [Related]
2. The in-vitro activity and beta-lactamase stability of carumonam.
Neu HC; Chin NX; Labthavikul P
J Antimicrob Chemother; 1986 Jul; 18(1):35-44. PubMed ID: 3531143
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic.
Imada A; Kondo M; Okonogi K; Yukishige K; Kuno M
Antimicrob Agents Chemother; 1985 May; 27(5):821-7. PubMed ID: 3874598
[TBL] [Abstract][Full Text] [Related]
4. In-vitro evaluation of carumonam (Ro 17-2301).
Stobberingh EE; Houben AW; van Boven CP
J Antimicrob Chemother; 1986 Sep; 18(3):345-50. PubMed ID: 3490467
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of a new cephalosporin ME-1206 compared with other agents.
Chin NX; Zhang YX; Neu HC
Diagn Microbiol Infect Dis; 1991; 14(5):417-24. PubMed ID: 1797456
[TBL] [Abstract][Full Text] [Related]
6. Aztreonam: antibacterial activity, beta-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests.
Barry AL; Thornsberry C; Jones RN; Gavan TL
Rev Infect Dis; 1985; 7 Suppl 4():S594-604. PubMed ID: 3909316
[TBL] [Abstract][Full Text] [Related]
7. [Comparative antibacterial activity of a new monobactam, carumonam (RO 17-2301, AMA 1080) on hospital bacteria resistant to beta lactams].
Le Noc P; Croize J; Le Noc D
Pathol Biol (Paris); 1987 May; 35(5):451-6. PubMed ID: 3302846
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of carumonam (RO 17-2301), BMY-28142, aztreonam, and ceftazidime against 7,620 consecutive clinical bacterial isolates.
Fuchs PC; Jones RN; Barry AL; Ayers LW; Gavan TL; Gerlach EH
Diagn Microbiol Infect Dis; 1986 Nov; 5(4):345-9. PubMed ID: 3536278
[TBL] [Abstract][Full Text] [Related]
9. Carumonam's in-vitro activity against gram-negative bacteria and its stability to their beta-lactamases.
Raimondi A; Mattina R; Cocuzza CE
Chemioterapia; 1988 Feb; 7(1):3-9. PubMed ID: 3288365
[TBL] [Abstract][Full Text] [Related]
10. Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830).
Jones RN; Barry AL
Diagn Microbiol Infect Dis; 1989; 12(6):495-510. PubMed ID: 2560422
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro antimicrobial activity of carumonam, a new monocyclic beta-lactam.
Smith BR; LeFrock JL; McCloskey RV; Donato JB; Weber SJ; Joseph WS
Antimicrob Agents Chemother; 1986 Feb; 29(2):346-9. PubMed ID: 3087280
[TBL] [Abstract][Full Text] [Related]
12. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli].
Thabaut A; Meyran M; Huerre M
Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217
[TBL] [Abstract][Full Text] [Related]
13. [In vitro activity of carumonam (RO 17-2301) on hospital bacteria].
Soussy CJ; Le Van Thoi J; Duval JR
Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):573-6. PubMed ID: 3534745
[TBL] [Abstract][Full Text] [Related]
14. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity and beta-lactamase stability of a new monobactam, B0-1165.
Neu HC; Chin NX
Antimicrob Agents Chemother; 1987 Apr; 31(4):505-11. PubMed ID: 3300528
[TBL] [Abstract][Full Text] [Related]
16. The cefoperazone-sulbactam combination. In vitro qualities including beta-lactamase stability, antimicrobial activity, and interpretive criteria for disk diffusion tests.
Jones RN; Barry AL; Thornsberry C; Wilson HW
Am J Clin Pathol; 1985 Oct; 84(4):496-504. PubMed ID: 2994461
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of carumonam (Ro 17-2301; AMA-1080) versus enteropathogenic and nonfermentative gram-negative rods and Legionella pneumophila.
Hohl P; von Graevenitz A; Zollinger-Iten J
Antimicrob Agents Chemother; 1988 Oct; 32(10):1593-4. PubMed ID: 3190188
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem.
Neu HC; Chin NX; Saha G; Labthavikul P
Antimicrob Agents Chemother; 1986 Dec; 30(6):828-34. PubMed ID: 3545068
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro activity of carumonam (Ro 17-2301/AMA-1080), a new monobactam, and ceftriaxone against aerobic or facultative gram-negative isolates.
Barclay CA; Iribarren MA; Goldberg M; Traballi CA; Casellas JM
Chemotherapy; 1987; 33(3):165-71. PubMed ID: 3595259
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial properties of carumonam (Ro 17-2301, AMA-1080), a new sulfonated monocyclic beta-lactam antibiotic.
Angehrn P
Chemotherapy; 1985; 31(6):440-50. PubMed ID: 3935396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
